• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

移植心脏中的冠状动脉内膜增厚。免疫和代谢危险因素的体内冠状动脉超声研究。

Coronary artery intimal thickening in the transplanted heart. An in vivo intracoronary untrasound study of immunologic and metabolic risk factors.

作者信息

Rickenbacher P R, Kemna M S, Pinto F J, Hunt S A, Alderman E L, Schroeder J S, Stinson E B, Popp R L, Chen I, Reaven G, Valantine H A

机构信息

Division of Cardiovascular Medicine, Stanford University School of Medicine, California 94305, USA.

出版信息

Transplantation. 1996 Jan 15;61(1):46-53. doi: 10.1097/00007890-199601150-00011.

DOI:10.1097/00007890-199601150-00011
PMID:8560573
Abstract

This study examined the hypothesis that immunologic factors are the major correlates of coronary artery intimal thickening and luminal stenosis. The study population included 116 adult heart transplant recipients with a mean age of 44.7 +/- 12.0 years (89 men and 27 women) undergoing annual coronary angiography and intracoronary ultrasound 3.4 +/- 2.7 (range, 1.0-14.6) years after transplantation. Mean intimal thickness was obtained from several distinct sites along the left anterior descending and/or left circumflex coronary artery by intracoronary ultrasound. Coronary artery stenosis defined by angiography was classified as mild (< 30% luminal stenosis), moderate (> or = 30-70% luminal stenosis), or severe (> 70% luminal stenosis or diffuse pruning of distal vessels). Prevalence of any transplant coronary artery disease (TxCAD) was 85% by intracoronary ultrasound and 15% by angiography. By multiple regression analysis, only average fasting plasma triglyceride level (P < 0.006) and average weight (P < 0.007) were significantly correlated with severity of intimal thickening (R = 0.54, P < 0.0001). Donor age (P < 0.006) and average fasting plasma triglyceride level (P < 0.009) were significantly correlated with stenosis by angiography. Correlation of multiple immunologic and metabolic factors with intimal thickness by univariate analysis suggests a multifactorial etiology for TxCAD. Among the multiple univariate correlates of TxCAD, higher fasting plasma triglyceride levels and body weight are the only independent correlates of TxCAD. The absence of acute rejection as an independent predictor of intimal thickening suggests that mechanisms beyond those mediating typical cellular rejection should be targeted for advancing our understanding of Tx-CAD.

摘要

本研究检验了免疫因素是冠状动脉内膜增厚和管腔狭窄主要相关因素这一假说。研究对象包括116例成年心脏移植受者,平均年龄44.7±12.0岁(89例男性和27例女性),在移植后3.4±2.7(范围1.0 - 14.6)年接受年度冠状动脉造影和冠状动脉内超声检查。通过冠状动脉内超声从左前降支和/或左旋支冠状动脉的几个不同部位获取平均内膜厚度。血管造影定义的冠状动脉狭窄分为轻度(管腔狭窄<30%)、中度(管腔狭窄≥30 - 70%)或重度(管腔狭窄>70%或远端血管弥漫性截断)。通过冠状动脉内超声检查,任何移植冠状动脉疾病(TxCAD)的患病率为85%,血管造影检查为15%。通过多元回归分析,仅平均空腹血浆甘油三酯水平(P<0.006)和平均体重(P<0.007)与内膜增厚严重程度显著相关(R = 0.54,P<0.0001)。供体年龄(P<0.006)和平均空腹血浆甘油三酯水平(P<0.009)与血管造影显示的狭窄显著相关。单因素分析中多种免疫和代谢因素与内膜厚度的相关性提示TxCAD的多因素病因。在TxCAD的多个单因素相关因素中,较高的空腹血浆甘油三酯水平和体重是TxCAD仅有的独立相关因素。急性排斥反应不存在作为内膜增厚的独立预测因素,这表明除了介导典型细胞排斥反应的机制之外,还应针对其他机制来增进我们对Tx - CAD的理解。

相似文献

1
Coronary artery intimal thickening in the transplanted heart. An in vivo intracoronary untrasound study of immunologic and metabolic risk factors.移植心脏中的冠状动脉内膜增厚。免疫和代谢危险因素的体内冠状动脉超声研究。
Transplantation. 1996 Jan 15;61(1):46-53. doi: 10.1097/00007890-199601150-00011.
2
Prognostic importance of intimal thickness as measured by intracoronary ultrasound after cardiac transplantation.
Circulation. 1995 Dec 15;92(12):3445-52. doi: 10.1161/01.cir.92.12.3445.
3
Exercise echocardiography in heart transplant recipients: a comparison with angiography and intracoronary ultrasonography.
J Heart Lung Transplant. 1994 Jul-Aug;13(4):604-13.
4
Correlation of donor characteristics with transplant coronary artery disease as assessed by intracoronary ultrasound and coronary angiography.
Am J Cardiol. 1995 Aug 15;76(5):340-5. doi: 10.1016/s0002-9149(99)80097-6.
5
Intracoronary ultrasound in cardiac transplant recipients. In vivo evidence of "angiographically silent" intimal thickening.心脏移植受者的冠状动脉内超声检查。“血管造影隐匿性”内膜增厚的体内证据。
Circulation. 1992 Mar;85(3):979-87. doi: 10.1161/01.cir.85.3.979.
6
Transplant coronary artery disease in pediatric heart transplant recipients.小儿心脏移植受者的移植冠状动脉疾病
J Heart Lung Transplant. 2000 Mar;19(3):240-8. doi: 10.1016/s1053-2498(99)00139-4.
7
Importance of decreased heart rate in predicting transplant coronary artery disease.心率降低在预测移植后冠状动脉疾病中的重要性。
Clin Transplant. 1997 Dec;11(6):628-32.
8
Influence of intimal thickening on coronary blood flow responses in orthotopic heart transplant recipients. A combined intravascular Doppler and ultrasound imaging study.内膜增厚对原位心脏移植受者冠状动脉血流反应的影响。一项血管内多普勒与超声成像联合研究。
Circulation. 1995 Nov 1;92(9 Suppl):II182-90. doi: 10.1161/01.cir.92.9.182.
9
Glucose intolerance, as reflected by hemoglobin A1c level, is associated with the incidence and severity of transplant coronary artery disease.糖化血红蛋白水平所反映的葡萄糖不耐受与移植冠状动脉疾病的发生率和严重程度相关。
J Am Coll Cardiol. 2004 Mar 17;43(6):1034-41. doi: 10.1016/j.jacc.2003.08.063.
10
Feasibility of serial intracoronary ultrasound imaging for assessment of progression of intimal proliferation in cardiac transplant recipients.
Circulation. 1994 Nov;90(5):2348-55. doi: 10.1161/01.cir.90.5.2348.

引用本文的文献

1
Vessel Fractional Flow Reserve and Graft Vasculopathy in Heart Transplant Recipients.心脏移植受者的血管分数流量储备和移植物血管病变。
J Interv Cardiol. 2020 Jul 12;2020:9835151. doi: 10.1155/2020/9835151. eCollection 2020.
2
Cardiac allograft vasculopathy and insulin resistance--hope for new therapeutic targets.心脏移植血管病变与胰岛素抵抗——新治疗靶点的希望
Endocrinol Metab Clin North Am. 2007 Dec;36(4):965-81; ix. doi: 10.1016/j.ecl.2007.07.012.
3
Pharmacotherapy of hyperlipidemia in pediatric heart transplant recipients: current practice and future directions.
小儿心脏移植受者高脂血症的药物治疗:当前实践与未来方向。
Paediatr Drugs. 2005;7(6):391-6. doi: 10.2165/00148581-200507060-00007.